Skip to main content

memo - Magazine of European Medical Oncology

Ausgabe 3/2024

Inhalt (17 Artikel)

  • editorial

ASH 2023

Niklas Zojer

  • editorial

Molecular tumor board—editorial

Hossein Taghizadeh, Armin Gerger

  • Open Access
  • review

15 years Ludwig Boltzmann Institute for Hematology and Oncology (LBI HO): achievements and future perspectives

Peter Valent, Emir Hadzijusufovic, Irina Sadovnik, Thomas W. Grunt, Barbara Peter, Michael Willmann, Harald Herrmann, Daniel Ivanov, Gregor Eisenwort, Heidrun Karlic, Georg Greiner, Karoline V. Gleixner, Thomas Rülicke, Maik Dahlhoff, Philipp Staber, Wolfgang R. Sperr, Michael Pfeilstöcker, Thomas Lion, Felix Keil, Gregor Hoermann

  • short review

Trends in MDS and AML from ASH 2023

Michael Pfeilstöcker

  • Open Access
  • short review

Liquid profiling for patients with advanced cancer is ready for clinical integration

Samantha O. Hasenleithner, Ellen Heitzer

  • Open Access
  • short review

The molecular tumor board—a key element of precision oncology

Laura Boos, Andreas Wicki

  • Open Access
  • short review

Liquid biopsy in breast cancer

Eva Valentina Klocker, Christoph Suppan

  • Open Access
  • short review

Antibody–drug conjugates (ADCs) in lung cancer treatment

Romana E. Wass, David Lang, Andreas Horner, Bernd Lamprecht

  • Open Access
  • short review

Importance of allogeneic stem cell transplantation in myelofibrosis

Klaus Hirschbühl, Christoph Schmid

  • original report

β-adrenergic modulation of IL-6/gp130 and SOCS-1 in multiple myeloma: therapeutic strategy for stress induced-inflammatory response

Raika Naiebi, Saeid Abroun, Amir Atashi, Leila Shafiee, Mohammadarian Akbari, Mohammad Hasan Maleki, Morvarid Siri

  • Open Access
  • case report

Seminal vesicle metastasis from transverse colon adenocarcinoma: a unique case report

Juliana Arenas Hoyos, Julian Serrano Giraldo, Andres Felipe Gutierrez Rojas

Aktuelle Ausgaben

Scrollen für mehr

Benutzen Sie die Pfeiltasten für mehr

Scrollen oder Pfeiltasten für mehr